AUROBINDO PHARMA LTD. - Clarifies on News item

	< Back
22 Jul 2015
With reference to the news article in The Economic Times, on July 22, 2015 captioned "Aurobindo Pharma Comes Under US FDA Lens", Aurobindo Pharma Ltd has Clarified to BSE as under:<BR><BR>"the said facility underwent a routine GMP inspection by USFDA and there are certain observations related to the systems and procedures. The Company is appropriately responding and this has no perceived impact on the operations and exports from the said facility."
View all announcements for AUROBINDO PHARMA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us